Salt Lake City, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, announced today that it will present a ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

Additionally, Recursion shared promising results from its ongoing Phase 1b/2 TUPELO trial for the drug REC-4881, showing significant polyp reduction in patients with familial adenomatous polyposis.

The Forge—a Roblox RPG meets mining sim—throws a ton at you just within those first few minutes of questing, cave exploration, and crafting. It's a little more serious about the RPG part of the ...

What makes a great fitness tracker for beginners? And what are some of the best options to look for ahead of January? We’ve got you covered. When you purchase through links on our site, we may earn an ...

Jan is ready for a new challenge. She's recently moved to Colorado and wants to take advantage of the new terrain and start mountain running. Before the move, she'd been working on her fitness for ...

Muscle growth, or hypertrophy, is more than just lifting heavy weights. For beginners, understanding the science behind bulking can make the process safer, faster, and more effective. Here's a ...

Investing seems complex when you first start, but picking the right investment funds for beginners can make it much more straightforward, and give you an easy on-ramp to building your wealth over the ...